John de Groot
Professor · University of California (San Francisco) School of Medicine
Credentials: · · · ·
History
- 2005–2006
Clinical Neurophysiology
Research
Journal of Clinical Oncology · 2010 · 3,116 citations
Guidelines for the use and interpretation of assays for monitoring autophagy
Autophagy · 2012 · 2,918 citations
Chimeric antigen receptor T-cell therapy - assessment and management of toxicities
Case report · Nature Reviews Clinical Oncology · 2018 · 1,951 citations
- PW
45 papers
32 papers
29 papers
23 papers
22 papers
21 papers
21 papers · 9 as a fellow
19 papers
Grants
- 2008–2019
National Cancer Institute · P50
Project lead · $1.2M · University of Tx Md Anderson Can Ctr
- 2010–2014
Modulation of Resistance to Antiangiogenic Therapy: A Clinical Trial with Correla
National Cancer Institute · R21
Contact PI · $645.9K · University of Tx Md Anderson Can Ctr
- 2007–2010
Predictive Markers of Glioblastoma Response to VEGF Trap
National Cancer Institute · R21
Contact PI · $585.2K · University of Tx Md Anderson Can Ctr
Clinical trials
- 2014–2018
Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma
Principal investigator · Terminated · Phase 2
SynerGene Therapeutics, Inc.
- 2011–2014
Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)
Principal investigator · Terminated · Phase 1, Phase 2
M.D. Anderson Cancer Center
- 2008–2011
Measuring Non-Enhancing Glioblastoma Progression
Principal investigator · Completed
M.D. Anderson Cancer Center
- 2008–2014
Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I
Principal investigator · Terminated · Phase 1
M.D. Anderson Cancer Center